The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

10.1002/1097-0142(195609/10)9:5<927::AID-CNCR2820090510>3.0.CO;2-3

Feinleib M, 1968, J Natl Cancer Inst, 41, 315

Rosner B, 1994, Am J Epidemiol, 139, 819, 10.1093/oxfordjournals.aje.a117079

Cauley JA, 1989, Am J Epidemiol, 129, 1120, 10.1093/oxfordjournals.aje.a115234

10.1002/ijc.2910440105

10.1016/0021-9681(79)90119-X

Colditz GA, 1993, Am J Obstet Gynecol, 168, 1473, 10.1016/S0002-9378(11)90784-4

Pike MC, 1993, Epidemiol Rev, 15, 17, 10.1093/oxfordjournals.epirev.a036102

Committee on the relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine. Oral contraceptives & breast cancer. Washington, D.C.: National Academy Press, 1991.

10.1007/BF00051356

10.1093/jnci/81.17.1313

10.1001/jama.262.20.2853

Stampfer MJ, 1984, Am J Epidemiol, 119, 837, 10.1093/oxfordjournals.aje.a113804

Cox DR, 1972, J R Stat Soc [B], 34, 187

10.1002/ijc.2910420510

10.1056/NEJM198908033210505

10.1111/j.1471-0528.1987.tb03166.x

Stanford JL, 1993, Epidemiol Rev, 15, 98, 10.1093/oxfordjournals.epirev.a036120

Gambrell RD, 1983, Obstet Gynecol, 62, 435

Kaufman DW, 1991, Am J Epidemiol, 134, 1375, 10.1093/oxfordjournals.aje.a116041

Palmer JR, 1991, Am J Epidemiol, 134, 1386, 10.1093/oxfordjournals.aje.a116042

10.1007/BF00051360

Rose DP, 1977, Obstet Gynecol, 49, 80

Jurgens RW, 1992, Am J Obstet Gynecol, 167, 459, 10.1016/S0002-9378(11)91429-X

10.1016/0378-5122(78)90015-4

10.1056/NEJM198606193142505

10.1016/0277-5379(88)90173-3

Morrison AS, 1979, Am J Epidemiol, 109, 709, 10.1093/oxfordjournals.aje.a112734

10.1038/bjc.1986.246

10.1001/jama.257.2.209

10.1056/NEJM199310143291601

10.1056/NEJM199310143291610